Is Cusp Overlapping Projection the New Self-Expandable Valve Implantation Technique?

In Europe and the US, aortic stenosis is the most frequent cause of valve intervention, both surgical and percutaneous, and, as we all know, TAVR has made great progress in this regard. 

¿Fin de la discusión sobre el impacto del marcapaso post TAVI?

However, this technique has an Achilles heel when it comes to self-expandable valves: definite pacemaker implantation rate is 3 to 4 times higher with TAVR vs surgery. This generates major costs, higher risk of inhospital complications and, at followup, higher tricuspid failure.

Higher implantation or Cusp Overlapping Projection (COP) might solve this inconvenience.

The present study looked at 444 patients undergoing TAVR. 175 of these procedures were done using the CPO technique (39.4%) and the rest, the standard technique. 

Even though the populations were similar, there were some differences in age, hypertension, stroke, STS score and the presence of first-degree AV-block. 

Read also: Cusp Overlap for Higher CoreValve Implantation.

Mean gradient was 45 mmHg, perimeter was 74 mm and calcium score 2,587 U Agatston.

Procedural success rate was 96%. The most used access was right femoral, 30% required pre-dilation and 30.9% post-dilation.

Mortality was 0.23, stroke 1.1, valve embolization was 0.4, major bleeding was 1.1 and high degree A-V block, 12.2%. There were no differences between the groups but the need for definite pacemaker was lower with COP (12.6 vs. 21.2% (P= 0.02; RR: 0.59; 95% CI: 0.38-0.93)), as was depth measured from the non-coronary cusp to distal prostheses end: 4.2 mm vs.5.14 mm (P=<0.001)

Read also: Tricuspid valve: Is Percutaneous Intervention Feasible in Patients with Definite Pacemaker?

To match the populations researchers used Propensity Score, which left 161 pairs of patients. There were no differences in characteristics, or evolution, which were similar to prior results. 

The need for definite pacemaker implantation was lower in the COP population: 11.8% vs 21.7% respectively (P = 0.03; RR: 0.54; 95% CI: 0.32-0.91), aa was mean implantation depth measured from non-coronary sinus 4.2±2.1 mm vs. 5.3±2.6 mm (P < 0.001).

Conclusion

The present study showed that the COP technique significantly reduces the need for pacemaker implantation with self-expandable valves compared to the standard technique, with similar complications rate. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board, SOLACI.org

Original Title: Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR A Propensity Score Analysis.

Reference: Isaac Pascual, et al. J Am Coll Cardiol Intv 2022;15:150–161.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...